Vse
VSEC· Services· Fiscal year ends in December
CEO pay in FY2025Stock +81.7% in FY2025
John A. Cuomo is the CEO of Vse and was paid $9.0M in FY2025 (Dec), up 81%.
Pay$100 in the stock at the end of FY20 → $457
Executives3
See all- 1John A. CuomoCEO and PresidentFY2025
- 2Adam R. CohnChief Financial OfficerFY2025
- 3Benjamin E. ThomasChief Operating OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allVse paid its 3 named executives $13.4M in total in FY2025 (Dec). CEO John A. Cuomo was paid $9.0M of that.
| Name | |||
|---|---|---|---|
| John A. CuomoCEO and President | |||
| Adam R. CohnChief Financial Officer | Not disclosed | ||
| Benjamin E. ThomasChief Operating Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Vse. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board8
See all- Bonnie K. WachtelDirector · 34 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive
- John E. PotterDirector · 11 yr on the boardIndependentCompensation and Human Resources (Chair), Nominating and Corporate Governance—Paid as an executive
- John A. CuomoDirector · 6 yr on the boardNot independent—Paid as an executive
- Anita D. BrittDirector · 3 yr on the boardIndependentAudit (Chair), Compensation and Human Resources—Paid as an executive
- Edward P. DolanskiDirector · 3 yr on the boardIndependentAudit, Compensation and Human Resources—Paid as an executive
- Lloyd E. JohnsonDirector · 3 yr on the boardIndependentCompensation and Human Resources, Nominating and Corporate Governance—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Mar 24, 2026 | FY2025 |
| Annual report | 10-K | Feb 27, 2026 | FY2025 |
| Proxy statement | DEF 14A | Mar 25, 2025 | FY2024 |
| Annual report | 10-K | Mar 3, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 2, 2024 | FY2023 |
| Annual report | 10-K | Mar 8, 2024 | FY2023 |
